1. Barth, M., Bondoux, M., Luccarini, J.-M., et al., From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists, J. Med. Chem., 2012, vol. 55, no. 6, pp. 2574–2584.
2. Donoghue, M., Hsieh, F., Baronas, E., et al., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9, Circ. Res., 2000, vol. 87, pp. E1–E9. https://doi.org/10.1161/01.res.87.5.e1
3. Dubilei, P.V., Urazaeva, Z.V., and Khamitov, Kh.S., Bar’ernaya funktsiya legkikh i obespechenie gomeostaza (Barrier Function of Lungs and Homeostasis), Kazan: Kazan. Gos. Univ., 1987.
4. Eliseeva, Yu.E. and Orekhovich, V.N., Isolation and study of the specificity of carboxycatepsin, Dokl. Akad. Nauk SSSR, 1963, vol. 153, no. 4, pp. 954–956.
5. Fang, C. and Schmaier, A.H., Novel antithrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems, Pharmacol. Res., 2020, vol. 160, p. 105096. https://doi.org/10.1016/j.phrs.2020.105096